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Background: The pig is a biomedical model to study human and livestock traits. Many of these traits are controlled
by neuropeptides that result from the cleavage of prohormones by prohormone convertases. Only 45 prohormones
have been confirmed in the pig. Sequence homology can be ineffective to annotate prohormone genes in
sequenced species like the pig due to the multifactorial nature of the prohormone processing. The goal of this
study is to undertake the first complete survey of prohormone and prohormone convertases genes in the pig
genome. These genes were functionally annotated based on 35 gene expression microarray experiments. The
cleavage sites of prohormone sequences into potentially active neuropeptides were predicted.
Results: We identified 95 unique prohormone genes, 2 alternative calcitonin-related sequences, 8 prohormone
convertases and 1 cleavage facilitator in the pig genome 10.2 assembly and trace archives. Of these, 11 pig
prohormone genes have not been reported in the UniProt, UniGene or Gene databases. These genes are
intermedin, cortistatin, insulin-like 5, orexigenic neuropeptide QRFP, prokineticin 2, prolactin-releasing peptide, parathyroid
hormone 2, urocortin, urocortin 2, urocortin 3, and urotensin 2-related peptide. In addition, a novel neuropeptide S was
identified in the pig genome correcting the previously reported pig sequence that is identical to the rabbit
sequence. Most differentially expressed prohormone genes were under-expressed in pigs experiencing immune
challenge relative to the un-challenged controls, in non-pregnant relative to pregnant sows, in old relative to
young embryos, and in non-neural relative to neural tissues. The cleavage prediction based on human sequences
had the best performance with a correct classification rate of cleaved and non-cleaved sites of 92% suggesting that
the processing of prohormones in pigs is similar to humans. The cleavage prediction models did not find
conclusive evidence supporting the production of the bioactive neuropeptides urocortin 2, urocortin 3, torsin family
2 member A, tachykinin 4, islet amyloid polypeptide, and calcitonin receptor-stimulating peptide 2 in the pig.
Conclusions: The present genomic and functional characterization supports the use of the pig as an effective
animal model to gain a deeper understanding of prohormones, prohormone convertases and neuropeptides in
biomedical and agricultural research.
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In addition to the importance in livestock production, the
pig is a well-established biomedical model to study human
health due to the genomic, anatomic and physiologic simi-
larities with humans. A wide variety of human health
traits including cancer, reproductive health, drug metabol-
ism, wound healing, and cardiovascular disease have been
successfully studied using the pig [1-4]. Underlying these* Correspondence: rodrgzzs@illinois.edu
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reproduction in any medium, provided the orand other important traits such as growth and develop-
ment, feeding, stress, memory and susceptibility to sub-
stances abuse are neuropeptides, a class of cell-cell
signaling peptides that have paracrine, endocrine, and
autocrine effects [5,6]. Research in selected pig neuropep-
tides has offered insights into cell transplantation, nervous
system diseases, and injury [7]. For example, Yang et al.
[8] reported on the inhibitory effect of neuromedin S
(NMS) on luteinizing hormone secretion which is
mediated via melanocyte-stimulating hormone (MSH) neu-
rons in the hypothalamus-pituitary axis of ovariectomized
pigs. Kaminski et al. [9] concluded that hypothalamicLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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trol of food intake, sleep patterns, autonomic and neuroen-
docrine systems, and may also affect reproductive functions
through the influence on the hypothalamic-pituitary-
ovarian axis in pigs.
The identification of neuropeptides is more difficult
than most proteins because neuropeptides are derived
from larger prohormone proteins as a result of complex
enzymatic processing. The conversion of the large prohor-
mone to one or multiple smaller neuropeptides involves
cleavage by multiple prohormone convertases and add-
itional post-translational modifications such as amidation
and glycosylation [5]. This complex processing of prohor-
mones into neuropeptides challenges the identification of
neuropeptide genes across genomes solely based on se-
quence homology to better understood species [5,6,10].
Only 40 prohormone and 2 prohormone convertase
genes have been empirically confirmed in the pig com-
pared to approximately 100 genes identified in human,
rat, mouse, cow and rhesus monkey [11-13]. This partial
knowledge of the prohormone, prohormone convertase
and associated neuropeptides in the pig is a critical
shortcoming, especially considering the important role
of pig in biomedical and agricultural research [1]. In
addition, few gene expression studies have discussed the
expression profile of pig prohormone or prohormone
convertase genes. Ross et al. [14] found that estradiol
treatment at day 9 of gestation was associated with
changes in the expression of the prohormone neuromedin
(NMB) in the endometrium of glits. Hausman et al. [15]
concluded that the expression of neuropeptide Y (NPY)
was down-regulated with age in gilts ranging from 90 to
210 days old.
Understanding the role of neuropeptides in human
and livestock traits using the pig as biomedical model
requires a comprehensive knowledge of the neuropep-
tide complement in the recently released pig genome
(SScrofa 10.2v18, [16]). This understanding includes the
identification of prohormone and prohormone conver-
tase genes, prediction of cleavage sites in prohormones
that may result in potentially bioactive neuropeptides,
and characterization of gene expression and protein
abundance across conditions to gain insights into the
role of neuropeptides. A complete survey of the prohor-
mone and prohormone convertase genes in the pig sup-
ports the interpretation of gene expression experiments
and improves the effectiveness of tandem mass spec-
trometry studies to identify neuropeptides [17-19]. Func-
tional annotation of these genes can be obtained by the
analysis of the large number of gene expression experi-
ments already available [20,21]. To address the lack of a
comprehensive understanding of the prohormone and
prohormone convertase genes in the pig, we present the
first comprehensive survey and functional annotation ofthese genes. An all-inclusive catalogue of prohormone
and prohormone convertase genes known in other spe-
cies was used to search complementary pig genome
databases. These genes were then characterized by ana-
lyzing a large number of gene expression experiments
across a wide range of conditions. The potential cleavage
sites of prohormones that can result in bioactive neuro-
peptides were predicted and compared to the cleavages
based on known neuropeptide sequences.
Results and discussion
Pig prohormone genes
A comprehensive catalogue of 95 potential pig prohor-
mone genes, 8 prohormone convertase genes and 1 pro-
hormone convertase facilitator gene (7B2) were identified
in the pig genome. Table 1 lists the genes and the corre-
sponding BLAST matches on the pig Genome, UniProt,
Gene and UniGene databases. There are 11 previously un-
reported (i.e. without empirical confirmation) prohor-
mone genes in the pig and complete sequences where
only partially or incomplete sequences have been previ-
ously reported. Newly identified genes are intermedin
(ADM2), cortistatin (CORT), insulin-like 5 (INSL5), orexi-
genic neuropeptide QRFP (OX26), prokineticin 2 (PROK2),
prolactin-releasing peptide (PRRP), parathyroid hormone 2
(TIP39), urocortin (UCN1), urocortin 2 (UCN2), urocortin 3
(UCN3), and urotensin 2-related peptide (UTS2B). This
search also identified two different calcitonin protein en-
tries in public databases that are isoforms of other calci-
tonin genes. Additional information on the comprehensive
catalogue of genes is available [see Additional file 1]. The
predicted prohormone protein sequences with cleavage
sites identification is provided in the NeuroPred format
[see Additional file 2].
Table 2 summarizes the evidence from various reposi-
tories supporting the 95 unique pig prohormone genes
and 2 alternative sequences detected in this study. The
genome-predicted prohormone genes are supported by
66 UniProt entries (Table 1) including 47 sequences that
have evidence at the protein level of which 39 have
complete protein sequence and 8 have partial protein se-
quence. Additionally, 81, 91 and 19 prohormone genes
detected are supported by transcript evidence from
UniGene, Gene, and UniProt, respectively. Two genes,
apelin (APEL) and PROK2, are supported by evidence in
UniProt and by EST records unassigned to a UniGene
cluster. UniProt supporting information includes 2 entries
from alternatively spliced calcitonin genes, preprocalcitonin
gene-related peptide and calcitonin-2, that have evidence at
the protein and transcript levels, respectively. However, the
calcitonin 2 is not assigned to a UniGene cluster or
NCBI Gene identifier because no EST matches the unique
region of the reported sequence. The UniProt entry for
prothyroliberin (TRH) refers only to the 3-amino acid
Table 1 Prohormone and convertase genes identified across pig genome resources
Typea Symbol Gene name Genome sequenceb UniGenec UniProtd Genee
P ADM2 Intermedin complete Not Found F1RXU1 100517471
P ADM5 Adrenomedullin-5 complete Ssc.26627 A5LHG2 100101476
P ADML Adrenomedullin complete Ssc.314 P53366 397195
P ANF Atrial natriuretic factor complete Ssc.16245 P24259 397496
P ANFB Natriuretic peptide B complete Ssc.629 P07634 396844
P ANFC C-type natriuretic peptide complete Ssc.23867 P18104 493772
P APEL Apelin complete CU928865 Not Found 100625006
P AUGN Augurin complete Ssc.22487 F1SU23 100512958
P CALC Calcitonin/calcitonin gene-related peptide 1 complete Ssc.14052 A6P7L6 100125547
P CALCalt Preprocalcitonin gene-related peptide complete Ssc.56129 A6P7L7 100124407
P CART Cocaine- and amphetamine-regulated transcript protein complete Ssc.15900 Q307W6 397252
P CCKN Cholecystokinin complete Ssc.717 P01356 397468
P CMGA Chromogranin-A complete Ssc.4653 P04404 397540
P COLI Pro-opiomelanocortin complete Ssc.14556 P01192 396863
P CORT Cortistatin complete Not Found F1RIF7 100526112
P CRF Corticoliberin complete Ssc.69887 P06296 100127468
P CRSP1 Calcitonin receptor-stimulating peptide 1 complete Ssc.3741 Q862B1 396563
P CRSP2 Calcitonin receptor-stimulating peptide 2 complete Ssc.18558 Q766Y7 396574
P CRSP3 Calcitonin receptor-stimulating peptide 3 complete Ssc.17879 Q766Y6 396573
P CRSP3alt Calcitonin-2 complete Not Found A0A761 Not Found
P EDN1 Endothelin-1 complete Ssc.9364 P09558 396915
P EDN2 Endothelin-2 complete Not Found Not Found Not Found
P EDN3 Endothelin-3 complete Ssc.31972 A5A752 100049663
P GALA Galanin complete Ssc.713 P07480 397465
P GALP Galanin-like peptide complete Ssc.4875 Q9TT95 396772
P GAST Gastrin complete Ssc.644 P01351 445524
P GHRL Obestatin complete Ssc.440 Q9GKY5 396728
P GIP Gastric inhibitory polypeptide complete Ssc.38713 P01281 100621117
P GLUC Glucagon complete Ssc.17225 P01274 397595
P GON1 Progonadoliberin-1 complete Ssc.16310 P49921 397516
P GON2 Progonadoliberin-2 Not Found Not Found F1S8B1 100523475
P GRP Gastrin-releasing peptide complete Ssc.13923 P63153 Not Found
P HEPC Hepcidin complete Ssc.376 Q8MJ80 397207
P IAPP Islet amyloid polypeptide complete Ssc.8324 Q29119 100520838
P IGF1 Insulin-like growth factor 1 complete Ssc.16231 P16545 397491
P IGF2 Insulin-like growth factor 2 fragment Ssc.9365 P23695 396916
P INS Insulin complete Ssc.583 P01315 397415
P INSL3 Insulin-like 3 complete Ssc.11990 P51461 397024
P INSL5 Insulin-like 5 complete Not Found Not Found 100620109
P INSL6 Insulin-like 6 complete Ssc.46919 F1SK47 100158105
P KISS1 Metastasis-suppressor KiSS-1 complete Ssc.73565 B5M447 100145896
P MCH Pro-melanin-concentrating hormone complete Ssc.3287 Q9TTS8 396962
P MOTI Motilin complete Ssc.714 P01307 397466
P NEU1 Oxytocin complete Ssc.15668 P01177 100152272
P NEU2 Neurophysin-2 complete Ssc.4210 P01183 396995
P NEUT Neurotensin complete Ssc.38680 F1SPX3 100739079
P NMB Neuromedin-B complete Ssc.2083 B0LUW4 100141313
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Table 1 Prohormone and convertase genes identified across pig genome resources (Continued)
P NMS Neuromedin-S complete Ssc.12508 C3UZJ1 100294685
P NMU Neuromedin-U complete Ssc.12508 P34964 100523263
P NPB Neuropeptide B complete Ssc.82498 Not Found Not Found
P NPFF Neuropeptide FF complete Ssc.44958 F1SFP1 100518250
P NPS Neuropeptide S complete Ssc.73596 F1RSG4 100188981
P NPW Neuropeptide W complete Ssc.15796 Q8MI35 396680
P NPY Neuropeptide Y complete Ssc.15981 P01304 397304
P OREX Orexin complete Ssc.15983 O77668 397305
P OSTN Osteocrin (Musclin) complete Ssc.5148 A5JHN9 100049691
P OX26 Orexigenic neuropeptide QRFP complete Not Found F1S0X5 100524361
P PACA Pituitary adenylate cyclase-activating polypeptide complete Ssc.27598 P41535 414283
P PAHO Pancreatic polypeptide complete Ssc.456 P01300 397272
P PCSK1N Proprotein convertase subtilisin/kexin type 1 inhibitor complete Ssc.17429 Not Found 100621697
P PDGFA Platelet-derived growth factor alpha polypeptide complete Ssc.6173 F1RIZ0 100519764
P PDGFB Platelet-derived growth factor beta polypeptide complete Ssc.54182 P20034 100126843
P PDGFD Platelet-derived growth factor D complete Ssc.49835 F1SV50 100524161
P PDYN Proenkephalin-B complete Ssc.121 P01214 445529
P PENK Proenkephalin complete Ssc.11281 Q7M3H2/Q7M2Z7 100152093
P PNOC Prepronociceptin complete Ssc.15910 P55791 397257
P PROK2 Prokineticin 2 fragment EW633867 Not Found 100526076
P PRRP Prolactin-releasing peptide fragment Not Found Not Found Not Found
P PTHR Parathyroid hormone-related peptide complete Ssc.9991 Q866H2 396951
P PTHY Parathyroid hormone complete Ssc.668 P01269 399502
P PYY Peptide YY complete Ssc.63650 P68005 445018
P REL1 Pro-relaxin 1 complete Ssc.162 P01348 396891
P REL3 Relaxin 3 complete Ssc.42647 Q8HY17 503836
P RES18 Regulated endocrine-specific protein 18 complete Ssc.49266 F1SR77 100154377
P RFRP Neuropeptide VF precursor complete Ssc.75350 C4P9W1 100302024
P SCG1 Secretogranin-1 complete Ssc.15718 Q9GLG4 397154
P SCG2 Secretogranin-2 complete Ssc.13645 Q5FZP5 497237
P SCG3 Secretogranin-3 complete Ssc.6770 F1RYP7 100154760
P SECR Secretin complete Ssc.710 P63298 397464
P SLIB Somatoliberin complete Ssc.71374 P01287 100499556
P SMS Somatostatin complete Ssc.19520 P01168 494469
P SPXN Spexin complete Ssc.57764 F1SR03 100155886
P TIP39 Parathyroid hormone 2 complete Not Found F1RHZ 100515141
P TKN1 Tachykinin, precursor 1 complete Ssc.18075 F1SF85 100525179
P TKN4 Tachykinin-4 complete Ssc.23153 F1RTB7 100511101
P TKNK Tachykinin 3 complete Ssc.19565 P67934 492314
P TOR2X Torsin family 2, member A fragment Ssc.67158 B6VD08 100519815
P TRH Prothyroliberin complete Not Found P62968 100513309
P UCN1 Urocortin Traces Not Found F8R6K7 Not Found
P UCN2 Urocortin 2 complete Not Found F1SKM2 100521865
P UCN3 Urocortin 3 complete Not Found F1RYW0 100737810
P UTS2 Urotensin 2 complete Ssc.437 Q95J46 397268
P UTS2B Urotensin II-related peptide complete Not Found F1SFH3 100626084
P VEGFC Vascular endothelial growth factor C complete Ssc.12790 F1RT19 100525960
P VEGFD Vascular endothelial growth factor D complete Ssc.29289 F1SQU4 100155670
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Table 1 Prohormone and convertase genes identified across pig genome resources (Continued)
P VGF Neurosecretory protein VGF fragment Ssc.90772 Not Found 100624333
P VIP Vasoactive intestinal peptide complete Ssc.47759 E0Y441 100500718
C 7B2 Neuroendocrine protein 7B2 (secretogranin 5) complete Ssc.155 P01165 397110
C FURIN Furin complete Ssc.94009 F1RMJ1 100156882
C PCSK1 Proprotein convertase subtilisin/kexin type 1 PC1/3 complete Ssc.92884 Q28959 397103
C PCSK2 Proprotein convertase subtilisin/kexin type 2 complete Ssc.109 Q03333 445533
C PCSK4 Proprotein convertase subtilisin/kexin type 4 complete Ssc.47037 Not Found 100626523
C PCSK5 Proprotein convertase subtilisin/kexin type 5 incomplete Ssc.43614 Not Found 100519237
C PCSK6 Proprotein convertase subtilisin/kexin type 6 incomplete Ssc.73551 F1RZ92 100152144
C PCSK7 Proprotein convertase subtilisin/kexin type 7 complete Ssc.5628 F1SJT0 100523009
C PCSK9 Proprotein convertase subtilisin/kexin type 9 complete Ssc.84357 Not Found 100620501
a P: prohormone gene, C: prohormone convertase gene.
b Genome sequence found: complete or incomplete in the pig genome assembly, found in the Traces archive, or Not Found in any genome repository.
c,d,e Identifiers in the UniGene, UniProt and Gene databases.
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reported. Only 8 genome predictions do not have support-
ing evidence in UniProt with 5 of these have supporting
transcript evidence. Complete protein sequences were
predicted for insulin-like 5 (INSL5) and endothelin-2
(EDN2) and an incomplete protein sequence was pre-
dicted for prolactin-releasing peptide (PRRP) genes. The
nucleic and protein sequence of EDN2 have been reported
[22] but this information is not present in public data-
bases. Of the 23 UniProt predicted sequences, 14 (7) en-
tries have (do not have) transcript support. There are 2
UniProt predicted sequences that correspond to genes
that are absent in the pig genome studied. A partial match
to UCN1 was found in the trace archives although this
gene was not found in the pig genome assembly studied
and lacks of external validation. Progonadoliberin-2
(GON2) was not found in the current pig genome assem-
bly although this gene was detected in earlier assembly
versions and trace archives. This gene has no current ex-
perimental evidence outside homology to other mamma-
lian species. The apparent lack of UCN1 and GON2 in the
assembly and fragment evidence of other prohormones is
most likely due to poor coverage of the genomic regions
where these prohormone genes are located.
At least four calcitonin genes, also known as calcitonin
receptor-stimulating peptide genes, were identified with
2 genes exhibiting alternative splicing. The genome
assembly permitted the assignment of the UniProt
pre-procalcitonin (A6P7L6) and preprocalcitonin gene-
related peptide (A6P7L7) entries to the same gene that
also produces the UniProt calcitonin (CALC, [Swiss-Prot:
P01259]) and calcitonin gene-related peptide (CALCA,
[Swiss-Prot:P30880]) peptides, respectively. This alterna-
tively spliced gene corresponds to CALCA gene found in
other mammalian species.
The bioinformatics gene prediction pipeline confirmed
that the separate Q766Y6 and A0A761 UniProt entriesare alternatively spliced variants of the same calcitonin
receptor-stimulating peptide 3 (CRSP3) gene as initially
reported by Rezaeian et al. [23]. A single genome
match was identified for calcitonin receptor-stimulating
peptide 2 (CRSP2, Q766Y7). While the calcitonin receptor-
stimulating peptide 1 (CRSP1) gene has been reported, the
actual gene may be inaccurately assembled in the 10.2 gen-
ome release because the region appears to contain a small
duplication leading to 2 starting locations. Further support-
ing this argument, a conserved 19 amino acid region in
all calcitonin receptor-stimulating peptide-related protein
sequences matched to an additional 5th genome site
which was part of a discontinued NCBI Gene entry (Gene
ID 100624618). There is insufficient information to con-
clude whether there is a separate coding gene involved or
an assembly-related problem.
Neuropeptide S (NPS) is a potential 12th prohormone
gene discovered by the bioinformatics gene prediction pipe-
line. Two genome matches on different chromosomes for
the NPS gene were identified. However, the complete iden-
tity of the matched between the predicted sequence and
chromosomal locations implied that this was an assembly
error rather than a duplication event. Although UniProt
has an partial pig NPS entry (B5M997), the genome pre-
dicted protein sequence was more similar to the bovine se-
quence, as expected, than the present partial UniProt pig
sequence. The pig NPS protein and nucleic sequences were
found to be 100% and 99% identical, respectively, to the
rabbit sequence ([GenBank:EU978456]). The similarity be-
tween the UniProt pig and rabbit sequences was also
evident in the phylogenetic relationships among NPS
sequences reported by Yao et al. [24]. These findings call
into question the present pig NPS entry in UniProt.
Prohormone genes previously unreported in pig
The genome search identified 11 prohormone genes that
do not have empirical confirmation in the UniProt,
Table 2 Distribution of the prohormone gene predictions across UniProt and UniGene resources
UniProt evidence1
Genome2 UniGene3 Protein Partial Transcript Predicted Not Found
complete Present 38 7 17 14 3
complete Not Found 0 1 1 7 2
fragment Present 1 0 1 0 2
fragment Not Found 0 0 0 0 1
Not Found Not Found 0 0 0 2 0
1 UniProt Evidence: “type of evidence that supports the existence of the protein”; Protein : complete protein sequence; Partial: incomplete protein sequence such
as presence of a peptide; Transcript: “existence of a protein has not been strictly proven but there is expression data (such as existence of cDNAs, RT-PCR or
Northern blots) that indicate the existence of a transcript.”; Predicted: Complete or partial sequence of the protein has been predicted; Not Found: no match
found in the UniProt database.
2 Genome: prediction of the protein sequence from the genome assembly: complete denotes full sequence, fragment denotes incomplete prediction and Not
Found denotes no match.
3 UniGene Present or Not Found denote whether the gene had any EST evidence or not, respectively.
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ADM2, CORT, INSL5, OX26, PROK2, PRRP, NPS, TIP39,
UCN1, UCN2, UCN3, and UTS2B. Only inferred
sequences are available for ADM2 and CORT in UniProt
and the current pig NPS entry is identical to the rabbit
NPS. There is evidence for mammalian homologs of all
these genes in UniProt. The protocol followed to identify
these genes included a high percentage of identities and
similarities with a minimum percentage of mismatches
and gaps and conservation of the region encompassing
the potential neuropeptide. Intermedin or adrenomedullin
2 (ADM2) is part of the calcitonin family of peptides and
has effects similar to those of adrenomedullin (ADML). In
humans, intermedin causes hypotension when given per-
ipherally and augments blood pressure and causes sympa-
thetic activation when given to the central nervous system
[25]. This neuropeptide induces prolactin release, has anti-
diuretic and natriuretic properties and reduces food intake.
The amino acid sequences of CORT and somatostatin
(SMS) are highly similar and both reduce neuronal activity.
In addition, CORT has unique roles such as induction of
slow-wave sleep, reduction of locomotor activity, and acti-
vation of cation selective currents not responsive to SMS
[26]. Although the function of INSL5 is still being deter-
mined, high expression in the colon, as well as in the brain
and hypothalamus, indicates roles in gut contractility and
neuroendocrine signaling [27]. Likewise, the function of
OX26 is still being elucidated, although studies in chicken
confirm the orexigenic, appetite stimulating activity of this
neuropeptide [28]. Takayanagi and Onaka [29] demon-
strated that PRRP plays a role in control of energy
metabolism and stress response. Prokineticins are
involved in tumorigenesis process (prostate, testicles,
neuroblastoma, colon, and pancreas) acting as a growth
factor for cancer cells, an angiogenic and a chemotactic
factor for pro-inflammatory neutrophils [30]. NPS has
anxiolytic-like effects (stress reduction) and can induce
arousal and wakefulness [31]. TIP39 and the correspond-
ing receptor form a neuromodulator system and theanatomical distribution indicates a role in limbic, endo-
crine, viscerosensory, and auditory functions. This system
has been postulated as potential drug target in anxiety, de-
pression and chronic pain management [32]. Urocortins
and their receptors has been found in the central nervous,
digestive, reproductive, cardiovascular, immune and endo-
crine systems, suggesting a variety of roles including car-
diovascular activity and cell survival [33]. UTSB2 is a
paralog of urotensin 2 (UTS2) that exerts similar biological
effects including relaxation of muscles and reduction of
blood pressure [34].
Pig prohormone convertase genes
The sequence of 8 prohormone convertase genes and
the 7B2 facilitator gene also known as secretogranin 5
(SCG5) were identified in the pig genome (Table 1). The
UniProt and Gene databases only had supporting evi-
dence for PCSK1, PCSK2, and 7B2. Six additional pro-
hormone convertase genes (furin, PCSK4, PCSK5,
PCSK6, PCSK7, and PCSK9) that were previously unre-
ported or not based on empirical evidence were identified.
Only transcript evidence supports the 8 prohormone con-
vertase genes, meanwhile protein evidence is available for
7B2. Dai et al. [35] isolated PCSK1 from the ovary cDNA
library of a pregnant sow and Renegar et al. [36] detected
PCSK1 in the corpus luteum and brain of pregnant sows.
Also, mRNA from PCSK1 and PCSK2 has been identified
in the pituitary neurointermediate lobes of pigs [37].
Among the prohormone convertases, furin, PCSK4,
PCSK5, PCKS6 and PCSK7 do not have UniGene entries.
The present catalogue enhances the currently limited
work on pig prohormone convertases.
Functional characterization of the pig prohormone and
prohormone convertase genes
Analysis of the large number of microarray gene expres-
sion experiments enabled the first comprehensive
characterization of the role of prohormone and prohor-
mone convertase genes in biological processes in the pig.
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standing of the role of these genes on reproduction,
health, growth, and other traits of importance to biomed-
ical research and agricultural production.
The query of Affymetrix Porcine Genome Array identi-
fied 77 probes representing 56 prohormone and 3 prohor-
mone convertase genes. Table 3 lists the total number of
differentially expressed probes (P-value < 0.005) within the
seven experimental classes considered. A detailed distribu-
tion of the differential expression level of each probe and
experiment is provided [see Additional file 3]. A discus-
sion of the findings for the 3 groups with highest number
of differentially expressed probes (immune-related, embryo
and placenta, and brain and central nervous system) is pre-
sented below. Although neuropeptides expressed in the
brain and the immune system interact with circulating
cytokines to support two-way communications between the
brain and immune system [38], we describe the profiles of
prohormones in immune-related tissues separately from
the brain and central nervous system tissues to facilitate the
interpretation of results.
Immune-related profiling
Several studies have demonstrated that prohormone genes
play an important role in pig immune response [39]. This
was evidenced by the high number of differentially
expressed prohormone and prohormone convertase genes
(24 genes) among experiments that evaluated immune-
response in blood, spleen, and lymph nodes (Table 3). Dif-
ferentially expressed genes were: ADML, augurin (AUGN),
cholecystokinin (CCKN), CRSP3, endothelin-1 (EDN1),
galanin (GALA), galanin-like peptide (GALP), progonado-
liberin-1 (GON1), insulin-like growth factor I (IGF1), insu-
lin-like growth factor II (IGF2), neuromedin-B (NMB),
neuromedin-U (NMU), neuropeptide Y (NPY), platelet-
derived growth factor subunit A (PDGFA), proenkephalin-
A (PENK), prorelaxin 1 (REL1), secretogranin-1 (SCG1),
secretogranin-2 (SCG2), secretogranin-3 (SCG3), SMS,
vascular endothelial growth factor C (VEGFC), vascular
endothelial growth factor D (VEGFD), PCSK1 and PCSK7.
In general, prohormone genes were under-expressed
in pigs under immune challenge relative to the un-
challenged controls. AUGN was differentially expressed in
two experiments; GSE7313 [40] that profiled lymph nodes
and GSE14790 [41] that profiled blood. In GSE14790,
7 day-old pigs were inoculated with porcine circovirus
type 2 (PCV2), a virus that is widely spread across pig
farms, and gene expression was profiled at 0, 7, 14, 21 and
29 dpi. AUGN was over-expressed in un-inoculated pigs
at 29 dpi relative to 7 dpi, regardless of inoculation and
relative 21 dpi inoculated pigs (P-value < 2.5 × 10-4). Both
contrasts indicate that the expression of AUGN increases
with age and this trend is slower in pigs infected with
PCV2. In GSE7313, the gene expression of seven week oldpiglets inoculated with Salmonella Typhimurium was pro-
filed at 8 hours post inoculation (hpi), 24 hpi, 48 hpi, and
21 days post inoculation (dpi). AUGN was over-expressed
at 21 dpi relative to 24 hpi and 48 hpi (P-values < 6.8×10-5
and 2.7×10-6, respectively). Consistent with the differential
expression in relation to immune-response observed in this
study, AUGN is a putative tumor suppressor gene and is
down-regulated in many cancers [42].
IGF2, a member of the insulin family and is involved
in development and growth, was differentially expressed
across immune-related experiments. IGF2 was repre-
sented by 12 probes in the microarray platform and
6 probes were differentially expressed across experi-
ments. Five probes (Ssc.9365.1.S1_at, Ssc.9365.2.S1_a_at,
Ssc.9365.5.A1_at, Ssc.9365.5.S1_at, Ssc.9365.6.S1_x_at)
and one probe (Ssc.9365.3.S1_a_at) were differentially
expressed in experiments GSE14790 [41] and GSE7314
[43], respectively. In GSE14790, IGF2 was under-expressed
in non-inoculated piglets at 7 dpi relative to inoculated pigs
at various days (P-value <1.7× 10-5, fold change=0.71). In
experiment GSE7314, IGF2 was over-expressed in pigs
inoculated with Salmonella choleraesuis at 21 dpi relative
to non-inoculated pigs (P-value < 8.1 ×10-4). These results
are consistent with reports that IGF2 is down-regulated in
pigs immune-challenged with lipopolysaccharide [44].
SCG1, SCG2, SCG3, members of the secretogranin fam-
ily, exhibited differential expression among immune-
challenge experiments consistent with the known associ-
ation of these genes with cell activation, cytotoxicity and
microbial defense [45]. Probes on all 3 SCGs exhibited dif-
ferential expression on two immune-related experiments.
SCG1 and SCG2 are differentially expressed in GSE14790
while SCG3 was differentially expressed in GSE11787 [21].
In GSE11787 SCG3 was under-expressed in inocu-
lated pigs relative to controls (P-value < 1.2 × 10-3, fold
change = 0.33). These results are consistent with the
lack of synthesis of endogenous granins in rat PC12 cells
infected with recombinant vaccinia viruses [46]. In
GSE14790, SCG1 and SCG2 were under-expressed in
pigs inoculated with PCV2 relative to un-inoculated
control pigs (P-value < 1.8 × 10-4, fold change = 0.88 and
P-value < 1.5 × 10-5, fold change = 0.93, respectively).
Two members of the vascular endothelial growth factor
family, VEGFC and VEGFD, were under-expressed in
PCV2 inoculated pigs relative to control pigs (P-value <1.8
×10-5, fold change= 0.62) and also under-expressed at
early stages (7 dpi) relative to later stages (19 and 29 dpi)
in GSE14790. In agreement with these findings, a loss of
endothelial growth factor transcription and increase in
pro-inflammatory indicators were reported in the endo-
metrial lymphocytes of pigs at sites of fetal arrest [47].
NPY (probe Ssc.15981.1.A1_at) was under-expressed
in PCV2-inoculated pigs relative to control pigs
(P-value < 6.6 × 10-4) and, within infection level, NPY was
Table 3 Differentially expressed prohormone and prohormone convertase genes (P-value < 0.005) across 35 microarray
experiments by tissue class
Symbol Probea Imm.b Emb. CNS Repro. Musc. Fat Gut Total
Prohormone
ADM5 Ssc.26627.1.A1_at 0 0 1 0 0 0 0 1
ADML Ssc.314.1.S1_at 2 0 1 0 1 0 1 5
ANF Ssc.16245.1.S1_at 0 0 0 0 1 0 0 1
ANFB Ssc.629.1.S1_at 0 0 0 0 1 0 0 1
ANFC Ssc.23867.1.A1_at 0 1 1 0 0 0 0 2
AUGN Ssc.22487.1.S1_at 2 0 0 0 1 1 0 4
CART Ssc.15900.1.S1_at 0 1 1 0 0 0 0 2
CCKN Ssc.717.1.S1_at 1 0 0 1 1 0 0 3
CMGA Ssc.4653.1.S1_at 0 0 0 0 0 1 1 2
COLI Ssc.14556.1.S1_at 0 1 0 0 0 0 0 1
CRSP1 Ssc.3741.1.S1_at 0 0 0 0 0 0 0 0
CRSP2 Ssc.18558.1.S1_at 0 1 0 0 0 0 0 1
CRSP3 Ssc.17879.1.S1_at 1 0 0 0 0 0 0 1
EDN1 Ssc.9364.1.S1_at 2 0 0 0 0 1 0 3
GALA Ssc.713.1.S1_at 1 1 0 0 0 0 1 3
GALP Ssc.4875.1.S1_at 1 1 0 0 1 0 0 3
GAST Ssc.644.1.S1_at 0 1 0 0 0 0 0 1
GHRL Ssc.440.1.S1_at 0 0 0 0 0 0 0 0
GLUC Ssc.17225.1.S1_at 0 1 0 1 0 0 1 3
GON1 Ssc.16310.1.S1_at 1 1 0 0 0 0 0 2
HEPC Ssc.376.1.S1_at 0 0 0 0 0 0 0 0
IAPP Ssc.8324.1.A1_at 0 1 0 0 0 0 0 1
IGF1 Ssc.16231.1.S1_a_at 1 0 1 0 0 0 0 2
Ssc.16231.2.A1_a_at 0 0 0 0 0 0 0 0
Ssc.16231.3.S1_a_at 0 0 1 0 0 0 0 1
IGF2 Ssc.9365.1.S1_at 1 0 0 0 0 0 0 1
Ssc.9365.2.S1_a_at 1 1 0 0 0 1 0 3
Ssc.9365.3.S1_a_at 1 0 0 0 0 0 0 1
Ssc.9365.3.S1_x_at 0 0 0 0 0 0 0 0
Ssc.9365.4.S1_a_at 0 1 0 0 0 0 0 1
Ssc.9365.5.A1_at 1 0 0 0 0 0 0 1
Ssc.9365.5.S1_at 1 1 0 0 0 0 0 2
Ssc.9365.5.S1_a_at 0 0 0 0 0 1 0 1
Ssc.9365.6.A1_a_at 0 0 0 0 0 0 0 0
Ssc.9365.6.A1_x_at 0 0 0 0 0 0 0 0
Ssc.9365.6.S1_x_at 1 0 1 0 0 0 0 2
Ssc.9365.7.A1_x_at 0 0 0 0 0 0 0 0
INS Ssc.583.1.S1_at 0 0 0 0 0 0 0 0
INSL3 Ssc.11990.1.S1_at 0 1 0 0 0 0 0 1
MCH Ssc.3287.1.S1_at 0 0 0 0 0 0 0 0
MOTI Ssc.714.1.S1_at 0 0 0 0 0 0 0 0
NEU1 Ssc.15668.1.A1_at 0 0 0 0 0 0 0 0
NEU2 Ssc.4210.1.S1_at 0 0 0 0 1 0 0 1
NMB Ssc.2083.1.A1_at 1 0 0 0 0 0 0 1
NMU Ssc.12508.1.A1_at 1 0 0 0 0 0 0 1
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Table 3 Differentially expressed prohormone and prohormone convertase genes (P-value < 0.005) across 35 microarray
experiments by tissue class (Continued)
NPW Ssc.15796.1.S1_at 0 1 0 0 0 0 0 1
NPY Ssc.15981.1.A1_at 1 1 0 0 1 0 0 3
Ssc.15981.1.S1_at 0 2 1 0 0 0 0 3
OREX Ssc.15983.1.S1_at 0 0 0 0 0 0 0 0
PACA Ssc.27598.1.S1_at 0 1 0 0 0 0 0 1
PAHO Ssc.456.1.S1_at 0 1 0 0 0 0 0 1
PCSK1N Ssc.17429.1.S1_at 0 1 0 1 0 0 0 2
PDGFA Ssc.6173.3.S1_a_at 1 0 1 0 0 0 1 3
PDYN Ssc.121.1.S1_at 0 1 1 0 0 0 0 2
PENK Ssc.11281.1.A1_at 0 1 0 1 0 1 1 4
Ssc.11281.2.S1_at 1 1 0 0 0 0 0 2
PNOC Ssc.15910.1.A1_at 0 0 0 0 0 0 0 0
Ssc.15910.1.S1_at 0 0 0 0 0 0 0 0
PTHR Ssc.9991.1.S1_at 0 1 1 2 0 0 0 4
PTHY Ssc.668.1.S1_at 0 1 0 0 0 0 0 1
REL1 Ssc.162.1.S1_at 1 1 0 0 0 0 0 2
SCG1 Ssc.15718.1.A1_at 1 1 0 0 0 0 1 3
SCG2 Ssc.13645.1.A1_at 1 0 0 0 0 1 1 3
SCG3 Ssc.6770.1.A1_at 1 1 0 1 0 0 0 3
SECR Ssc.710.1.S1_at 0 1 0 0 0 0 0 1
SMS Ssc.19520.1.A1_at 1 1 0 0 1 0 0 3
TKN1 Ssc.18075.1.A1_at 0 0 0 0 0 0 0 0
Ssc.18075.2.S1_at 0 1 0 0 0 0 0 1
TKN4 Ssc.23153.1.S1_at 0 0 0 0 0 0 0 0
TKNK Ssc.19565.1.S1_at 0 0 0 0 0 0 0 0
Ssc.19565.2.A1_at 0 0 0 0 0 0 0 0
UTS2 Ssc.437.1.S1_a_at 0 1 0 0 0 0 0 1
VEGFC Ssc.12790.1.A1_at 1 1 1 0 1 0 1 5
VEGFD Ssc.29289.1.A1_at 1 1 0 0 0 0 0 2
Total 30 35 12 7 10 7 9 110
Prohormone Convertase
PCSK1 Ssc.141.1.S1_at 1 1 0 0 0 0 1 3
PCSK2 Ssc.109.1.S1_at 0 0 0 0 0 0 0 0
PCSK7 Ssc.5628.1.S1_at 1 1 0 0 0 0 1 3
Total 2 2 0 0 0 0 2 6
aAffymetrix microarray gene probe identifier.
b Experiment classes: Imm: primary immune-response tissues, Emb: embryo and placenta, CNS: brain and central nervous system, Repro: reproduction, Musc:
muscle, fat, and gut.
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GSE14790. Consistent with these findings, the levels of
NPY mRNA decreased in the blood of rats treated with
vinblastine, an anti-cancer drug known to decrease the
number of white blood cells of the immune system
involved in defense [48]. Similarly, NPY was found to
decrease in cattle infected with Bovine Spongiform
Encephalopathy [49].
ADML was differentially expressed in GSE14758-D
and GSE7314. In GSE14758-D [41], ADML wasunder-expressed in the mediastinal lymph nodes of
PCV2-infected pigs relative to control pigs at 29 dpi
(P-value < 1.7 × 10-3, fold change = 0.6). Whereas, in
GSE7314 ADML was over-expressed at 48 dpi in the
blood of pigs inoculated with Salmonella choleraesuis rela-
tive to controls (P-value 4.8 × 10-3). The latter result is
consistent with the up-regulation of ADML gene expres-
sion and increases in systemic circulatory concentra-
tions of ADML in response to the onset and progression
of trauma, infection, and sepsis [50]. The apparent
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ciated with the differential effects that ADML has on cel-
lular metabolism, immune function, endocrine function,
and cardiovascular function.
Of the 3 prohormone convertases available in the
microarray platform, PCSK1 and PCSK7 were signifi-
cantly differentially expressed (P-value <1.3× 10-3) and
PCSK2 was marginally significantly differentially expressed
(P-value <6.5× 10-3) in GSE14790. PCSK1 was under-
expressed in PCV2-inoculated pigs already at 7 dpi relative
to 29 dpi, regardless of inoculation at the later stage
(P-value < 5.7 × 10-5). Likewise, PCSK7 is under-expressed
in PCV2-inoculated pigs relative to controls already at
7 dpi (P-value < 4.2 × 10-4) and, within controls, PCSK7
was under-expressed at early stages (7 dpi, 21 dpi) relative
to 29 dpi (P-value < 4.1 × 10-4). These results are in agree-
ment with similar findings that furin, another prohormone
convertase, was dysregulated in the immune cells of
advanced human atherosclerotic plaques [51] and imply
that prohormone convertase, like prohormone genes, are
down regulated under immune challenges.
Embryo and placenta profiling
In GSE18641 [52], IGF2 (probe Ssc.9365.2.S1_a_at) was
over-expressed in pregnant sows relative to non-
pregnant sows (P-value < 2.7 × 10–3, fold change 1.23).
In GSE12705 [20], IGF2 (probes Ssc.9365.4.S1_a_at and
Ssc.9365.5.S1_at) was over-expressed in earlier stages
(day 11 spherical and day 11 and 12 tubular) relative to
later stage (day 12 and 14 filamentous) conceptuses
(P-value < 2.1 × 10-4). This IGF2 profile is supported by
Pantaleon et al. [53] that showed that IGF2 is needed in
order for mouse embryos to progress from early stages to
blastocyst stages. Gupta et al. [54,55] reported that the ex-
pression of the embryo survival related gene IGF2 increased
with the addition of nonessential amino acids or phytohe-
maglutinin in pig embryos and blastocysts, respectively.
Both PENK probes were over-expressed in tubular and
spherical conceptuses relative to filamentous conceptuses
(P-value <2.6× 10-6) in experiment GSE12705 [20]. This is
consistent with results that found PENK mRNA to increase
linearly during gestation in the hippocampus of pigs [56].
PTHR was under-expressed in tubular and spherical rela-
tive to filamentous conceptuses (P-value <6.4×10-7, fold
change=0.02) in experiment GSE12705. This finding is
supported by reports that PTHR is present in higher con-
centrations in fetal pigs than in sows [56]. VEGFC is a rep-
resentative of the vascular endothelial growth factor family
of prohormones that have an important role in the survival
and mitogenesis of endothelial cells and lymphaniogenesis
and angiogenesis of embryos [57]. VEGFC was over-
expressed in pregnant sows relative to non-pregnant sows
(P-value <7.8× 10-4) in experiment GSE18641 [52]. This
finding is supported by a study in the chicken,demonstrating that the chorioallantoic membrane (analo-
gous to the placenta in mammals) contained growth of
embryonic microvessels stimulated by VEGFC [58]. The
expression profile is also supported by the finding that in
mice embryos,VEGFC is required for successful lymphatic
vasculature development and lymphatic endothelial cell
migration [59].Brain and central nervous system
Eleven differentially expressed prohormone genes were
identified in experiments concerning the hypothalamus,
thyroid, and olfactory bulb (neuroblasts). These genes are
Adrenomedullin-5 (ADM5), ADML, C-type natriuretic
peptide (ANFC), cocaine and amphetamine regulated
transcript protein (CART), IGF1, IGF2, NPY, platelet-
derived growth factor subunit A (PDGFA), prodynorphin
(PDYN), PTHR, and VEGFC.
ADML was over-expressed in the immortalized porcine
olfactory bulb neuroblasts relative to the non-neural epi-
thelial cells (P-value < 2.2 × 10-6, fold change > 10) in ex-
periment GSE16855 [60]. This result is supported by a
previous study that found that ADML is important for
regulation of proliferation and differentiation of neural
stem/progenitor cells using the mouse olfactory bulb [61].
IGF1 was over-expressed in the neuroblasts relative to
non-neural epithelial cells (average P-value < 5 × 10-7,
fold change > 10) in experiment GSE16855. This result is
supported by a study in chickens showing that IGF1 was
expressed in the olfactory bulb [62]. Also, IGF2 (probe
Ssc.9365.6.S1_x_at) was consistently over-expressed in
the hypothalamus of male Iberian pigs relative to all
other seven breed-gender combinations (on average,
P-value < 2.3 × 10-4, fold change = 2.42) in experiment
GSE14739-H [63,64]. NPY was over-expressed (P-
value < 8.1 × 10–4, fold change = 7.94) in neuroblasts
relative to non-neuronal cells in GSE16855. This re-
sult is consistent with reports that the olfactory bulb
exhibit high levels of immunoreactive NPY in the
brain of pigs [65] and that NPY may inhibit excitatory
neurotransmission in the rat olfactory bulb [66].
VEGFC was over-expressed in neuroblasts relative to
non-neuronal cells (P-value < 1.5 × 10-9, fold change > 10)
in experiment GSE16855. This result agrees with a 30%
increase in dividing neuroblasts in olfactory bulb in cul-
ture stimulated with VEGFC compared to controls
reported by Le Bras et al. [67]. PTHLH was under-
expressed in neuroblasts relative to non-neuronal cells
(P-value < 2.6 × 10-4, fold change= 0.20) in GSE16855. This
finding is consistent with reports that PTHLH may be a
negative regulator in the differentiation of chondrocytes
[68]. PDGFA was over-expressed in neuroblasts relative to
non-neuronal cells (P-value < 1.2 × 10-4) in experiment
GSE16855. Related to this result, Fressinaud et al. [69]
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glutamine synthetase activity in astrocytes in the brain.
Prediction of cleavage sites in pig prohormones
All 97 prohormone sequences were used to predict
cleavage and confirm the prediction against known or
predicted cleavage sites. These sequences were inferred
to have 228 cleavage sites that resulting in a 14.6%
prevalence rate (proportion of possible sites that are
cleaved). Most sites were cleaved at an arginine (R) such
that the most frequently cleaved motifs were xxKR
(71%), RxxR (34%) and xxRR (41%), where x denotes any
amino acid and K denotes lysine. There were 5% (38)
C-terminal single R sites that were cleaved without a basic
amino acid in the second and fourth positions preceding
the cleavage site (P2 or P4 locations, respectively).
The performance of the cleavage prediction models is
presented in Table 4. The correct classification rate ran-
ged from 82% to 92% indicating that a large proportion
of the sites were accurately predicted across all models.
The human cleavage prediction models had the best per-
formance for most of the statistics followed by the mam-
malian model. The Known Motif model provided the
highest number of true positive predictions but also the
highest number of false positive predictions. The Known
Motif model provided the highest sensitivity, 77%, indi-
cating more than three quarters of the cleaved sites were
correctly predicted as cleaved. However this model also
provided the highest number of false positive predic-
tions. Consequently the Known Motif positive predictive
power was 35% indicating that, on average, only 35% of
sites predicted to be cleaved are expected to be true
cleavage sites.
The human models provided the highest number of
true negatives resulting in the best model performance
compared to the Known Motif and mammalian models.
The human artificial neural network models had ap-
proximately 60% positive predictive power indicating
that most sites predicted as cleaved are expected to be
true positives. Although the human logistic models had
lower sensitivity than their artificial neural network
counterparts, the differences with the human artificial
neural network model were only 4 cleaved and 11 non-
cleaved sites. The high performance of the human mod-
els suggests that the cleavage of prohormones that result
in potential biologically active neuropeptides in the pig
is similar to humans. Noteworthy is that the mammalian
model was trained on 51 mammalian prohormones that
included 8 pig prohormones. This model provided
slightly more true positive predictions and a higher sen-
sitivity than the human logistic model. However, the
mammalian model had noticeably more false positive
predictions than the human logistic model resulting in
lower performance in the other accuracy measures.The comparison of results across models also provides
information on the accuracy of the cleavage assignment,
prediction accuracy and potential for a gene to produce
bioactive peptides. For 10 prohormones, at least 5 of the
models did not predict any cleavage site. However, it must
be noted that 4 of the prohormones (ANF, GHRL, IGF1
and PDGFD) are likely to have sites cleaved by proteases
other than prohormone convertases. For example, ANF is
cleaved by corin, serine peptidase (CORIN) [70].
Genes with no predicted cleavage or assigned cleavage
that differ from other species can be used to identify
proteins are not cleaved to form smaller peptides. There
is no evidence for cleavage of UCN2 and UCN3 to pro-
duce mature peptides in mammals [71]. All models
failed to predict two cleavage sites in TOR2X. The first
site, an N-terminal dibasic ‘RK’, is known to be rarely
cleaved across species [72]. The second site is a cleavage
found in humans that forms alpha- and beta-salusin but
this site may not be cleaved in the pig since the pig se-
quence, like the bovine sequence, only has a single basic
site instead of the human dibasic ‘RR’ site. Similarly for
TKN4, the genomic prediction and supporting EST data
indication a change from an R in other species to a gly-
cine amino acid in the pig sequence that may prevent
the formation of the ‘Hemokinin’ peptide.
The pig CRSP2 protein sequence lacks the ‘KR’ and a
C-terminal cleavage site that are cleaved in human
CALC and CALCB genes to produce Calcitonin gene-
related peptide 1 and Calcitonin gene-related peptide 2.
Therefore it is unlikely that pig CRSP2 would provide
these calcitonin peptides. The assigned cleavages in the
RES18 protein are necessary to provide a potential
triskadecapeptide peptide reported by Bloomquist et al.
[73]. This potential peptide has flanking dibasic cleavage
sites in the mouse and rat but this peptide has not been
experimentally confirmed. The corresponding region in
human, bovine and pig sequences are monobasic and
lack common PC cleavage motifs suggesting that these
species probably cannot form this peptide.
Examination of the potential cleavage sites in IAPP indi-
cated that a mutation from R to Q in the N-terminal
cleavage site is necessary to produce the Islet amyloid
polypeptide. Examination of the corresponding ESTs indi-
cated that 2 swine ESTs ([GenBank:AJ649149] and
[GenBank:AJ649469]) were 100% identical to the rat gen-
ome and consequently invalid sequences. Two other ESTs
([GenBank:EW569366], [GenBank:BF712755]) matched
the region that supported the genomic prediction. The
predicted protein sequence including the potential clea-
vages sites of the expected IAPP was less than 80% identi-
cal to other mammals sequences compared to typically
over 85% identity between the human and most other
mammalian sequences. Potter et al. [74] questioned the
capability of IAPP to form amyloids after examining the
Table 4 Performance of various cleavage prediction models to predict cleavage in pig prohormones
Performance Known Mammalian Human Logistic Human ANNd
Criteriaa Motif Logistic AAb AA Prop.c AA AA Prop.
True Positives 181 165 160 158 164 167
True Negatives 1520 1640 1724 1670 1735 1747
False Positives 329 209 125 179 114 102
False Negatives 54 70 75 77 71 68
Correct Classification 0.8162 0.8661 0.904 0.8772 0.9112 0.9184
Sensitivity 0.7702 0.7021 0.6809 0.6723 0.6979 0.7106
Specificity 0.8221 0.887 0.9324 0.9032 0.9383 0.9448
Positive predictive power 0.3549 0.4412 0.5614 0.4688 0.5899 0.6208
Negative predictive power 0.9657 0.9591 0.9583 0.9559 0.9607 0.9625
Correlation 0.4358 0.4856 0.5645 0.4944 0.5919 0.6184
AUC 0.8006 0.847 0.86 0.8186 0.8589 0.8802
a Performance criteria. True positives: number of correctly predicted cleaved sites; True negatives: number of correctly predicted non-cleaved sites; False positives:
number of incorrectly predicted cleaved sites; False negatives: number of incorrectly predicted non-cleaved sites; Correct classification rate: number of correctly
predicted sites divided by the total number of sites; Sensitivity (one minus false positive rate): number of true positives divided by the total number of sites
cleaved; Specificity (one minus false negative rate): number of true negatives divided by the total number of sites not cleaved; Positive predictive power: number
of true positives divided by the total number of sites predicted to be cleaved; Negative predictive power: number of true negatives divided by the total number
of sites predicted to not be cleaved; Correlation coefficient: Mathew’s correlation coefficient between observed and predicted cleavage; and AUC: Area under the
receiver operator characteristic or ROC curve relating sensitivity and 1-specificity.
b AA: models trained only on amino acids.
c AA prop: models trained with amino acids combined with the physicochemical properties of amino acids.
d ANN: artificial neural network approach.
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[GenBank:BF712755] EST sequence. The predicted pro-
hormone sequence and cleavage prediction results also
strongly suggest that the pig is unlikely to be able to form
IAPP. This reflects the importance of proteomic studies
involving cleavage to first determine that a species can
produce a peptide.
Conclusions
The pig is an important biomedical and agricultural re-
search species. Results from the first genome-wide study
of pig prohormone and prohormone convertase genes,
functional annotation and prediction of prohormone
cleavage have been presented. This study was enabled by
the availability of the pig genome sequence and of 35
gene expression experiments that evaluated a wide range
of conditions in pigs. These results offer more insights
into the role of neuropeptides on biological processes
such as reproduction, development, growth, and health
and support targeted empirical confirmation. The bio-
informatics pipeline used in this study can be used to
identify prohormones or other sets of genes in species
with similar sequence resources. Confirmatory insight
into the pig prohormones can be expected from prote-
omic mass spectrometry studies.
Combining complementary bioinformatic resources,
95 prohormone genes, 8 prohormone convertases and
one cleavage facilitator were discovered in the pig gen-
ome and raw sequence repositories. We uncovered 11
prohormone genes that have not been previously reported
and one potentially incorrectly reported. The high per-
formance of the models used to predict cleavage in the pig
prohormones suggests that the prohormone cleavage in
pigs is similar to humans. The analysis of 35 geneexpression experiments identified various neuropeptide
genes differentially expressed in immune-related tissues,
embryo and placenta and the central nervous system in-
cluding AUGN, IGF2, the family of SCGs, NPY, ADM and
ADML, PENK, PTHR, and VEGFC. Experiments are
required to confirm that the pig does not produce the bio-
active neuropeptides UCN2, UCN3, TOR2X, TKN4, IAPP,
and CRSP2 as suggested by the cleavage prediction
models.
Methods
Search for pig prohormone and convertase genes
A registry of approximately 100 candidate mammalian
prohormone and convertase genes was built from public
sequence databases (including NCBI Gene –release date
September 2011 [75], UniGene [76] – release date April
13 2011, and UniProt [77]–release 2011_11 November
16, 2011) and a literature review [11-13,19,78-80].
Candidate genes were searched for in the pig genome
10.2 assembly using the bioinformatics pipeline devel-
oped by Southey et al. [11,13]. The protein sequence of
each candidate gene in the registry was searched on the
pig genome assembly using the TBLASTN, BLASTP and
BLASTN programs from NCBI BLAST (version 2.18)
[81] with default parameters settings (E-value < 10 and
BLOSUM62 scoring matrix) and filtering disabled. In
addition, sequences not used in the pig genome assem-
bly (including unassigned genomic regions, whole gen-
ome shotgun sequencing and trace archives) were
searched when there was no suitable BLAST match to a
candidate gene or when the alignment to the genome as-
sembly suggested a missing genomic region. This strat-
egy allowed the annotation of genomic regions that were
partly or not included in the assembly.
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alignment score and E-value to identify the most likely
matches and genomic location of the corresponding pro-
hormone. The identified pig genomic region that
encompassed the BLAST match was further extended
approximately 500 base pairs to the 5′ and 3′ ends of
the match. Matches were also screened for alignments
to multiple homologous prohormone genes that could
indicate gene duplication events in the pig genome. The
gene parsing tool Wise2 [82] was used to predict the
protein sequence within the genome regions detected
with BLAST. The genomic region was further extended
when only a partial protein sequence was predicted. In
this study, Wise2 compared the target protein (prefer-
ence was given to pig protein sequences, followed by
human, cattle and other mammals) to the pig genomic
DNA sequence identified by BLAST to infer the gene
structure based on a model that includes introns and
frameshift errors. Each predicted gene was compared to
the UniProt and NCBI Gene databases to assess the ac-
curacy of the prediction based on previously reported
pig genes. To further confirm the Wise2 predictions, the
protein sequence predicted from the gene model was
also compared to the corresponding published mamma-
lian sequences using the multiple sequence alignment
tool Clustalw [83]. The multiple sequence alignment
maximized the likelihood of identifying homologous
genes. The predicted sequences were also searched
against the pig entries in the NBCI EST database to con-
firm the presence of the predicted protein sequence. The
pig entries in the NCBI EST database was also used to
complete the protein sequence when the genome cover-
age was incomplete.
Functional annotation of the pig prohormone and
convertase genes
A review of the pig microarray gene expression experi-
ments available in the NCBI GEO database [84] indi-
cated that the Affymetrix Porcine Genome Array
GPL3533 [85] was the most commonly used platform.
The UniGene database was searched for sequences that
represent prohormone and prohormone convertase
genes. This information was used to identify the probes
representing prohormone and prohormone convertase
genes in the Affymetrix Porcine Genome platform.
Thirty-five experiments that used the Affymetrix Por-
cine Genome platform were identified in GEO. Selected
experiments had a minimum of 6 microarrays and a max-
imum of 80 microarrays. The sources and main features
of these experiments are provided [see Additional file 4].
The wide range of selected microarray experiments avail-
able supported a comprehensive characterization of the
association of prohormone and associated neuropeptide
and convertase genes with various biological processes.The experiments were grouped into 7 classes: primary
immune-response tissues, embryo and placenta, brain
and central nervous system, reproduction, muscle, fat,
and gut. For experiments encompassing multiple tissues
(GSE14739, GSE18359, GSE13528), the samples corre-
sponding to each tissue were grouped and analyzed sep-
arately to facilitate the interpretation of results. The
number of GEO experiments in each within each class
were: immune: 6 (GSE7313, GSE7314, GSE11787, GSE1
7492, GSE14758-mediastinal lymph nodes, and
GSE14790); embryo and placenta: 5 (GSE18467, GSE1
8641, GSE18343, GSE11853, and GSE12705); brain and
nervous system: 5 (GSE16855, GSE12604, GSE14739-
hypothalamus, GSE14739-thyroid, and GSE14739-
adenohypophsis); reproduction: 2 (GSE11590, and
GSE14739-gonads); muscle: 7 (GSE18653, GSE19275,
GSE8974, GSE14643, GSE15211, GSE21096, and GSE
16348-skeletal muscle); fat: 8 (GSE17309, GSE14373,
GSE14739-fat, GSE9333, GSE18359-fat, GSE18359-liver,
GSE13528-fat and GSE13528-liver); gut: 2 (GSE14357 and
GSE15256).
The gene expression data were pre-processed and nor-
malized using the Affy R package [86]. Steps included
the log-2 transformation and GC-robust multichip aver-
age normalization of the gene expression measurements.
All probes in the platform were analyzed using ANOVA
to identify those that exhibited differential expression
across the conditions studied. The false discovery rate
[87] approach was used to adjust the statistical signifi-
cance of the differential expression and account for mul-
tiple testing across all probes. The normalization, one or
two-way ANOVA and multiple test adjustment of the
results were done using Beehive [88].
Prediction of cleavage sites
The location of the cleavage in pig prohormone proteins
that would result in potentially active neuropeptides was
predicted using NeuroPred [72]. Complete prohormone
sequences from UniProt were used to predict cleavage in
preference to the predicted sequences. In limited cases,
EST sequences were combined with the genomic data
and published partial sequences to predict the complete
prohormone sequence. For example, for Chromogranin-A
(CMGA), three glutamic acids were missing in the
genome-based predictions that were present in the corre-
sponding UniProt fragment sequence ([Swiss-Prot:
P04404]) and EST sequence [GenBank:EW261315] per-
mitted the prediction of the complete pig CMGA protein
sequence. The location of the potential cleavage sites in
the pig prohormones were inferred by homology to
human data.
Complementary cleavage prediction models trained on
confirmed cleavages from mammalian sequences [12,78,79]
were used to predict cleavages in the pig prohormone
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that searches for sites with specific combinations of basic
amino acid associated to cleavages reported in other species
[78], mammalian logistic regression [79], and human logis-
tic regression and artificial neural network models based on
amino acids only or amino acids combined with the physi-
cochemical properties of amino acids [12].
Known or predicted cleavage sites on all 97 prohor-
mone sequences were used to assess the performance of
the models to predict cleavage. The “observed” cleavage
sites known or inferred from homology to other species
based on a literature search [11-13,19,78-80] were com-
pared to the cleavage sites predicted by the models. The
counts of the true positives (number of correctly pre-
dicted cleaved sites), true negatives (number of correctly
predicted non-cleaved sites), false positives (the number
of incorrectly predicted cleaved sites) and false negatives
(number of incorrectly predicted non-cleaved sites) or
functions of the counts were used to assess the model
performance. These measurements were used to com-
pute the correct classification rate (number of correctly
predicted sites divided by the total number of all sites),
sensitivity (number of true positives divided by the total
number of cleaved sites), specificity (number of true
negatives divided by the total number of non-cleaved
sites), positive predictive power (number of true posi-
tives divided by the total number of sites predicted to be
cleaved), negative predictive power (number of true nega-
tives divided by the total number of sites predicted to not
be cleaved), Mathew’s correlation coefficient between
observed and predicted cleavage. The area under the re-
ceiver operator characteristic or ROC curve relating sensi-
tivity and 1 - specificity [78] was also calculated where area
values lower than 0.7 indicate poor model performance.Additional files
Additional file 1: Table S2. Prohormone and convertase genes
identified across multiple pig genome resources.
Additional file 2: Prohormone sequences and cleavage in
NeuroPred.
Additional file 3: Table S3. Statistical significance P-value
corresponding to the comparison between groups within experiment.
Additional file 4: Table S1. Main features of the 35 microarray
experiments analyzed.
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